Antimicrobial Resistance: Drug Pipeline Status and Global Mortality Projections
The Global Research on Antimicrobial Resistance (GRAM) Project forecasts that bacterial AMR will cause 39 million deaths between 2025 and 2050, equating to three deaths every minute. Two forces are colliding to produce this trajectory: resistance is accelerating fastest in the regions least equipped to contain it, while the antibiotic pipeline is generating only modest innovation against the pathogens of greatest concern. In May 2026, member states at the 79th World Health Assembly adopted the updated Global Action Plan on Antimicrobial Resistance for 2026-2036, marking the highest-level political commitment to the issue yet. For decision-makers in healthcare, pharmaceuticals, and public health policy, the structural mismatch between where resistance is killing people and where new treatments are being developed represents both a governance failure and a commercial opportunity that existing incentive structures have consistently failed to close.
Read the full analysis